Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
MDGL
Stock Latest News
The Fly
Madrigal Pharmaceuticals off highs, remains up 13% in afternoon trading
10d ago
MDGL
Premium
Company Announcements
Madrigal’s Rezdiffra Drives Blockbuster‑Level First Year
1M ago
MDGL
Premium
The Fly
Madrigal Pharmaceuticals price target lowered to $529 from $570 at BofA
1M ago
MDGL
Premium
Ratings
Madrigal Pharmaceuticals: Rezdiffra’s Strong Launch, Expanding Prescriber Adoption, and Advancing Pipeline Underpin Buy Rating
1M ago
MDGL
Premium
The Fly
Madrigal Pharmaceuticals reports Q4 EPS ($2.57), consensus (88c)
2M ago
MDGL
Premium
The Fly
Paulson buys Solstice, exits Honeywell in Q4
2M ago
BHC
Premium
Pre-Earnings
MDGL Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
MDGL
Premium
The Fly
Madrigal Pharmaceuticals announces exclusive license pact with Suzho Ribo
2M ago
MDGL
Premium
The Fly
Madrigal Pharmaceuticals price target lowered to $570 from $595 at BofA
2M ago
MDGL
Premium
Company Announcements
Madrigal Gains Expanded Patent Control Over Rezdiffra With Roche
2M ago
8K
MDGL
Premium
The Fly
Madrigal Pharmaceuticals initiated with an Overweight at Barclays
2M ago
MDGL
Premium
Weekend Updates
Madrigal, Clene, Cencora, Sequans, Amicus: Insider Moves Exposed
2M ago
COR
CLNN
Premium
The Fly
Madrigal Pharmaceuticals price target raised to $745 from $527 at Citizens
3M ago
MDGL
Premium
The Fly
Madrigal Pharmaceuticals price target raised to $644 from $554 at TD Cowen
3M ago
PFE
MDGL
Premium
Ratings
Madrigal: Expanding MASH Franchise and Combination Therapy Strategy Drive Raised Price Target and Reaffirmed Buy Rating
3M ago
MDGL
Premium
The Fly
Madrigal Pharmaceuticals expands MASH pipeline with global license agreement
3M ago
PFE
MDGL
Premium
The Fly
Morning Movers: OneStream surges following report of Hg takeover talks
3M ago
OS
DHI
Premium
The Fly
Wolfe downgrades Madrigal Pharmaceuticals to Peer Perform on valuation
3M ago
MDGL
Premium
The Fly
Madrigal Pharmaceuticals downgraded to Peer Perform from Outperform at Wolfe Research
3M ago
MDGL
Premium
Market News
These Are the Most and Least Likely Biotech Takeover Targets for 2026
3M ago
LLY
TFC
Premium
The Fly
Short Report: Vera Therapeutics bears retreat as stock rallies
3M ago
MBLY
MDGL
Premium
The Fly
Madrigal Pharmaceuticals price target raised to $900 from $540 at Piper Sandler
4M ago
MDGL
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
